• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Butterfly Network Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    6/13/24 4:15:20 PM ET
    $BFLY
    Medical Electronics
    Health Care
    Get the next $BFLY alert in real time by email
    0001804176false--12-310001804176us-gaap:WarrantMember2024-06-072024-06-070001804176us-gaap:CommonClassAMember2024-06-072024-06-0700018041762024-06-072024-06-07

    ​

    ​

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of the

    Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): June 7, 2024

    BUTTERFLY NETWORK, INC.

    (Exact name of registrant as specified in its charter)

    ​

    Delaware

    001-39292

    84-4618156

    (State or other jurisdiction of
    incorporation)

    (Commission File Number)

    (IRS Employer
    Identification No.)

    ​

    ​

    1600 District Avenue
    Burlington, Massachusetts

    ​
    01803

    (Address of principal executive offices)

    (Zip Code)

    ​

    Registrant’s telephone number, including area code: (781) 557-4800

    Not applicable

    (Former name or former address, if changed since last report)

    ​

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    ​

    Title of each class

    ​

    Trading Symbol(s)

    ​

    Name of each exchange on which registered

    Class A common stock, par value $0.0001 per share

    ​

    BFLY

    ​

    The New York Stock Exchange

    Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share

    ​

    BFLY WS

    ​

    The New York Stock Exchange

    ​

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company         ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

    ​

    ​

    ​

    ​

    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    As disclosed in Item 5.07 of this Current Report on Form 8-K, at the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) of Butterfly Network, Inc. (the “Company”) held on June 7, 2024, the Company’s stockholders approved the Butterfly Network, Inc. 2024 Employee Stock Purchase Plan (the “2024 ESPP”).

    ​

    A summary of the material terms and conditions of the 2024 ESPP is set forth as a part of Proposal 4 in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 26, 2024 and is incorporated herein by reference. That summary is qualified in its entirety by reference to the full text of the 2024 ESPP, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated in this Item 5.02 by reference.

    ​

    ​

    Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

    As disclosed in Item 5.07 of this Current Report on Form 8-K, the Third Amended and Restated Certificate of Incorporation (the “A&R Charter”), as amended from time to time, was approved by the Company’s stockholders at the Annual Meeting.

    ​

    On June 7, 2024, the Company filed the A&R Charter with the Secretary of State of the State of Delaware to amend and restate its Second Amended and Restated Certificate of Incorporation to (i) add a provision with respect to the automatic conversion of the Company’s Class B common stock effective February 12, 2028, which is seven years from the date of the closing of the business combination by and among Longview Acquisition Corp., Clay Merger Sub Inc., and BFLY Operations, Inc. (formerly Butterfly Network, Inc.) (the “Class B Conversion Amendment”), (ii) add a provision to provide for the exculpation of officers as permitted by recent amendments to Delaware law (the “Officer Exculpation Amendment”), and (iii) amend the exclusive forum provision (the “Exclusive Forum Amendment”).

    ​

    The foregoing description of the A&R Charter does not purport to be complete and is qualified in its entirety by reference to the full text of the A&R Charter, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated in this Item 5.03 by reference.

    ​

    ​

    Item 5.07 Submission of Matters to a Vote of Security Holders.

    On June 7, 2024, the Company held its 2024 Annual Meeting to consider and vote on the five proposals set forth below, each of which is described in detail in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 26, 2024.

    ​

    The following actions were taken at such meeting:

    ​

    1.The following nominees were re-elected to serve on the Company’s Board of Directors until the Company’s 2025 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, based on the following votes:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Nominee

    ​

    Votes For

    ​

    Votes Against

    ​

    Abstentions

    ​

    Broker Non-Votes

    Joseph DeVivo

        

    593,784,890

        

    1,098,165

        

    216,321

        

    51,242,848

    Jonathan M. Rothberg, Ph.D.

    ​

    593,358,531

    ​

    1,485,055

    ​

    255,790

    ​

    51,242,848

    Larry Robbins

    ​

    592,424,239

    ​

    2,447,570

    ​

    227,567

    ​

    51,242,848

    Dawn Carfora

    ​

    589,054,196

    ​

    5,761,633

    ​

    283,547

    ​

    51,242,848

    Elazer Edelman, M.D., Ph.D.

    ​

    593,003,607

    ​

    1,877,801

    ​

    217,968

    ​

    51,242,848

    S. Louise Phanstiel

    ​

    592,956,231

    ​

    1,860,535

    ​

    282,610

    ​

    51,242,848

    Erica Schwartz, M.D., J.D., M.P.H.

    ​

    593,037,435

    ​

    1,842,243

    ​

    219,698

    ​

    51,242,848

    ​

    ​

    2.The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified, based on the following results:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Votes For

    ​

    Votes Against

    ​

    Abstentions

    ​

    Broker Non-Votes

    645,115,686

    ​

    839,830

    ​

    386,708

        

    0

    ​

    ​

    3.On an advisory basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement was approved, based on the following votes:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Votes For

    ​

    Votes Against

    ​

    Abstentions

    ​

    Broker Non-Votes

    579,270,270

        

    15,449,010

        

    380,096

        

    51,242,848

    ​

    ​

    4.The Company’s 2024 ESPP was approved, based on the following votes:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Votes For

    ​

    Votes Against

    ​

    Abstentions

    ​

    Broker Non-Votes

    585,073,506

        

    9,775,826

        

    250,044

        

    51,242,848

    ​

    ​

    5.The A&R Charter, including the following material differences between the Company’s Second Amended and Restated Certificate of Incorporation and the A&R Charter, as amended from time to time, which were presented as three different separate subproposals, was approved, based on the following votes:

    ​

    (a)The Class B Conversion Amendment;

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Votes For

    ​

    Votes Against

    ​

    Abstentions

    ​

    Broker Non-Votes

    593,283,270

        

    1,310,039

        

    506,067

        

    51,242,848

    ​

    ​

    (b)The Officer Exculpation Amendment; and

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Votes For

    ​

    Votes Against

    ​

    Abstentions

    ​

    Broker Non-Votes

    585,160,638

        

    9,442,950

        

    495,788

        

    51,242,848

    ​

    ​

    (c)The Exclusive Forum Amendment.

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Votes For

    ​

    Votes Against

    ​

    Abstentions

    ​

    Broker Non-Votes

    591,236,597

        

    3,278,863

        

    583,916

        

    51,242,848

    ​

    ​

    No other matters were submitted to or voted on by the Company's stockholders at the Annual Meeting.

    ​

    ​

    Item 9.01    Financial Statements and Exhibits.

    (d)

    Exhibits.

    Exhibit No.

        

    Description

    3.1

     

    Third Amended and Restated Certificate of Incorporation, as amended, of the Registrant, as filed with the Secretary of the State of Delaware on June 7, 2024.

    10.1

    ​

    Butterfly Network, Inc. 2024 Employee Stock Purchase Plan.

    104

     

    Cover Page Interactive Data File (embedded within the Inline XBRL document)

    ​

    ​

    ​

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ​

    ​

    ​

    ​

    ​

     

    ​

    BUTTERFLY NETWORK, INC.

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    By:

    /s/ Heather C. Getz, CPA

    ​

    ​

    Name:

    Heather C. Getz, CPA

    ​

    ​

    Title:

    Executive Vice President and Chief Financial & Operations Officer

    ​

    ​

    ​

    ​

    Date: June 13, 2024

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Get the next $BFLY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BFLY

    DatePrice TargetRatingAnalyst
    8/1/2025Outperform → Perform
    Oppenheimer
    7/1/2025$3.00Buy
    Craig Hallum
    3/17/2025Outperform
    William Blair
    9/10/2024$3.00Buy
    Lake Street
    3/29/2023$2.25Neutral
    UBS
    11/29/2022$4.50Outperform
    Oppenheimer
    10/4/2022$9.50Buy
    B. Riley Securities
    12/17/2021$7.00Neutral
    UBS
    More analyst ratings

    $BFLY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Devivo Joseph sold $1,788,291 worth of shares (482,149 units at $3.71), decreasing direct ownership by 6% to 8,030,899 units (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    3/6/26 4:05:36 PM ET
    $BFLY
    Medical Electronics
    Health Care

    EVP, CFO Doherty John N. was granted 274,953 shares, increasing direct ownership by 22% to 1,509,641 units (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    3/4/26 4:13:21 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Chief Technology Officer Ku Victor was granted 287,326 shares, increasing direct ownership by 35% to 1,099,288 units (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    3/4/26 4:12:16 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Phanstiel S. Louise bought $571,160 worth of shares (185,261 units at $3.08) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    12/17/25 4:10:13 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Director Robbins Larry bought $64,471 worth of shares (21,370 units at $3.02) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    12/15/25 6:20:36 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Director Robbins Larry bought $4,652,773 worth of shares (1,558,541 units at $2.99) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    12/5/25 5:40:49 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.

    SCHEDULE 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

    3/17/26 4:20:28 PM ET
    $BFLY
    Medical Electronics
    Health Care

    SEC Form 144 filed by Butterfly Network Inc.

    144 - Butterfly Network, Inc. (0001804176) (Subject)

    3/5/26 4:42:18 PM ET
    $BFLY
    Medical Electronics
    Health Care

    SEC Form 144 filed by Butterfly Network Inc.

    144 - Butterfly Network, Inc. (0001804176) (Subject)

    3/3/26 4:54:46 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Butterfly Network Appoints David Horsley as Senior Vice President, Innovation – Butterfly Embedded™

    Chirp Microsystems Co-Founder Joins Butterfly to Advance its Ultrasound-on-Chip™ Platform Strategy Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of David Horsley, Ph.D. as Senior Vice President of Innovation – Butterfly Embedded™ to scale its Ultrasound-on-Chip™ co-development and licensing initiative. In this role, Dr. Horsley will lead strategy and go-to-market for Butterfly Embedded, overseeing new product development, partnerships, and commercialization efforts. Butterfly Embedded is focused on extending the reach of the company's proprietary semic

    3/10/26 8:05:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes

    Issued on behalf of VentriPoint Diagnostics Ltd.VANCOUVER, BC, March 3, 2026 /CNW/ -- USANewsGroup.com News Commentary -- AI is making its way through the halls of our entire medical system, and the implementation is accelerating at a great pace. The AI medical imaging market is projected to hit nearly $20 billion by 2033, growing at a 34.7% CAGR[1]. Echocardiography alone is forecast to grow to $2.64 billion by 2030 as hospitals demand cardiac platforms that prove economic value alongside clinical accuracy[2]. Companies like VentriPoint Diagnostics (TSXV:VPT) (OTCPK: VPTDF), Butterfly Network (NYSE:BFLY), Tempus AI (NASDAQ:TEM), RadNet (NASDAQ:RDNT), and GE HealthCare (NASDAQ:GEHC) are conv

    3/3/26 12:19:00 PM ET
    $BFLY
    $GEHC
    $RDNT
    Medical Electronics
    Health Care
    Medical Specialities
    Computer Software: Programming Data Processing

    Butterfly Network Reports Fourth Quarter 2025 Financial Results

    Delivered Record Annual and Quarterly Revenue Reported quarterly record Revenue of $31.5 million in Q4, representing 41% YoY growth Generated positive net cash flow of $6.3 million in Q4 and lowest annual cash usage in company history Midjourney partnership contributed $6.8 million of revenue in Q4, advancing Butterfly Embedded™ platform strategy Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced financial results for the fourth quarter and year ended December 31, 2025, and provided a business update. Joseph DeVivo, Butterfly's Presiden

    2/26/26 6:30:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Butterfly Network downgraded by Oppenheimer

    Oppenheimer downgraded Butterfly Network from Outperform to Perform

    8/1/25 12:44:19 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Craig Hallum initiated coverage on Butterfly Network with a new price target

    Craig Hallum initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $3.00

    7/1/25 8:24:04 AM ET
    $BFLY
    Medical Electronics
    Health Care

    William Blair initiated coverage on Butterfly Network

    William Blair initiated coverage of Butterfly Network with a rating of Outperform

    3/17/25 7:23:53 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Financials

    Live finance-specific insights

    View All

    Butterfly Network Reports Fourth Quarter 2025 Financial Results

    Delivered Record Annual and Quarterly Revenue Reported quarterly record Revenue of $31.5 million in Q4, representing 41% YoY growth Generated positive net cash flow of $6.3 million in Q4 and lowest annual cash usage in company history Midjourney partnership contributed $6.8 million of revenue in Q4, advancing Butterfly Embedded™ platform strategy Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced financial results for the fourth quarter and year ended December 31, 2025, and provided a business update. Joseph DeVivo, Butterfly's Presiden

    2/26/26 6:30:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcast before the market opens on February 26 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor

    2/3/26 8:01:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Reports Third Quarter 2025 Financial Results

    Delivered quarterly revenue of $21.5 million in Q3, representing 5% YoY growth. Reduced quarterly cash burn to $3.9 million, a new record low for quarterly cash usage. Reaffirmed full year revenue guidance and narrowed adjusted EBITDA guidance. Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the third quarter ended September 30, 2025, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, "We view this quarter as a period of foundational

    10/31/25 6:30:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Leadership Updates

    Live Leadership Updates

    View All

    Butterfly Network Appoints David Horsley as Senior Vice President, Innovation – Butterfly Embedded™

    Chirp Microsystems Co-Founder Joins Butterfly to Advance its Ultrasound-on-Chip™ Platform Strategy Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of David Horsley, Ph.D. as Senior Vice President of Innovation – Butterfly Embedded™ to scale its Ultrasound-on-Chip™ co-development and licensing initiative. In this role, Dr. Horsley will lead strategy and go-to-market for Butterfly Embedded, overseeing new product development, partnerships, and commercialization efforts. Butterfly Embedded is focused on extending the reach of the company's proprietary semic

    3/10/26 8:05:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Appoints John Doherty as Chief Financial Officer

    Seasoned finance leader brings over 25 years of leadership experience driving growth and transformation Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced the appointment of John Doherty as Executive Vice President, Chief Financial Officer, effective December 8, 2025. Doherty has more than 25 years of global financial leadership experience, guiding public and private companies through major growth, transformation, and strategic transactions across the technology and telecommunications industries. Doherty joins Butterfly from Kaltura, a global leader in video SaaS solut

    10/9/25 4:05:00 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Appoints Victor Ku as Chief Technology Officer

    Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care through portable, semiconductor-based ultrasound technology and intuitive software, today announced the appointment of Victor Ku as Senior Vice President and Chief Technology Officer (CTO). Victor will join the company in late September and will be responsible for leading Butterfly's global technology strategy, product development, and innovation roadmap. "Victor's deep expertise in semiconductor-based imaging and his proven ability to scale global product development make him a perfect fit for Butterfly's next phase of growth," said Joseph DeVivo, President and CEO of Butterfly Network. "His leadership will b

    9/9/25 8:00:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Butterfly Network Inc.

    SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

    9/3/24 7:10:06 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13D/A filed by Butterfly Network Inc.

    SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

    8/30/24 4:05:41 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13G/A filed by Butterfly Network Inc.

    SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

    7/8/24 4:32:42 PM ET
    $BFLY
    Medical Electronics
    Health Care